Copyright Reports & Markets. All rights reserved.

Global Female Oral Contraceptives Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Female Oral Contraceptives Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Combination Pill
    • 1.3.3 Progestin-only Pill
    • 1.3.4 Continuous Use Pill
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Female Oral Contraceptives Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Online Sales
    • 1.4.3 Offline Sales
  • 1.5 Global Female Oral Contraceptives Market Size & Forecast
    • 1.5.1 Global Female Oral Contraceptives Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Female Oral Contraceptives Sales Quantity (2021-2032)
    • 1.5.3 Global Female Oral Contraceptives Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Bayer
    • 2.1.1 Bayer Details
    • 2.1.2 Bayer Major Business
    • 2.1.3 Bayer Female Oral Contraceptives Product and Services
    • 2.1.4 Bayer Female Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Bayer Recent Developments/Updates
  • 2.2 Janssen Global Services
    • 2.2.1 Janssen Global Services Details
    • 2.2.2 Janssen Global Services Major Business
    • 2.2.3 Janssen Global Services Female Oral Contraceptives Product and Services
    • 2.2.4 Janssen Global Services Female Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Janssen Global Services Recent Developments/Updates
  • 2.3 Allergan,plc (Actavis)
    • 2.3.1 Allergan,plc (Actavis) Details
    • 2.3.2 Allergan,plc (Actavis) Major Business
    • 2.3.3 Allergan,plc (Actavis) Female Oral Contraceptives Product and Services
    • 2.3.4 Allergan,plc (Actavis) Female Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Allergan,plc (Actavis) Recent Developments/Updates
  • 2.4 Teva Pharmaceutical
    • 2.4.1 Teva Pharmaceutical Details
    • 2.4.2 Teva Pharmaceutical Major Business
    • 2.4.3 Teva Pharmaceutical Female Oral Contraceptives Product and Services
    • 2.4.4 Teva Pharmaceutical Female Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Teva Pharmaceutical Recent Developments/Updates
  • 2.5 Piramal Enterprises
    • 2.5.1 Piramal Enterprises Details
    • 2.5.2 Piramal Enterprises Major Business
    • 2.5.3 Piramal Enterprises Female Oral Contraceptives Product and Services
    • 2.5.4 Piramal Enterprises Female Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Piramal Enterprises Recent Developments/Updates
  • 2.6 Pfizer
    • 2.6.1 Pfizer Details
    • 2.6.2 Pfizer Major Business
    • 2.6.3 Pfizer Female Oral Contraceptives Product and Services
    • 2.6.4 Pfizer Female Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Pfizer Recent Developments/Updates
  • 2.7 Merck
    • 2.7.1 Merck Details
    • 2.7.2 Merck Major Business
    • 2.7.3 Merck Female Oral Contraceptives Product and Services
    • 2.7.4 Merck Female Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Merck Recent Developments/Updates
  • 2.8 Mankind Pharma
    • 2.8.1 Mankind Pharma Details
    • 2.8.2 Mankind Pharma Major Business
    • 2.8.3 Mankind Pharma Female Oral Contraceptives Product and Services
    • 2.8.4 Mankind Pharma Female Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Mankind Pharma Recent Developments/Updates
  • 2.9 Syzygy Healthcare
    • 2.9.1 Syzygy Healthcare Details
    • 2.9.2 Syzygy Healthcare Major Business
    • 2.9.3 Syzygy Healthcare Female Oral Contraceptives Product and Services
    • 2.9.4 Syzygy Healthcare Female Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Syzygy Healthcare Recent Developments/Updates
  • 2.10 Ferring B.V
    • 2.10.1 Ferring B.V Details
    • 2.10.2 Ferring B.V Major Business
    • 2.10.3 Ferring B.V Female Oral Contraceptives Product and Services
    • 2.10.4 Ferring B.V Female Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Ferring B.V Recent Developments/Updates

3 Competitive Environment: Female Oral Contraceptives by Manufacturer

  • 3.1 Global Female Oral Contraceptives Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Female Oral Contraceptives Revenue by Manufacturer (2021-2026)
  • 3.3 Global Female Oral Contraceptives Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Female Oral Contraceptives by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Female Oral Contraceptives Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Female Oral Contraceptives Manufacturer Market Share in 2025
  • 3.5 Female Oral Contraceptives Market: Overall Company Footprint Analysis
    • 3.5.1 Female Oral Contraceptives Market: Region Footprint
    • 3.5.2 Female Oral Contraceptives Market: Company Product Type Footprint
    • 3.5.3 Female Oral Contraceptives Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Female Oral Contraceptives Market Size by Region
    • 4.1.1 Global Female Oral Contraceptives Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Female Oral Contraceptives Consumption Value by Region (2021-2032)
    • 4.1.3 Global Female Oral Contraceptives Average Price by Region (2021-2032)
  • 4.2 North America Female Oral Contraceptives Consumption Value (2021-2032)
  • 4.3 Europe Female Oral Contraceptives Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Female Oral Contraceptives Consumption Value (2021-2032)
  • 4.5 South America Female Oral Contraceptives Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Female Oral Contraceptives Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Female Oral Contraceptives Sales Quantity by Type (2021-2032)
  • 5.2 Global Female Oral Contraceptives Consumption Value by Type (2021-2032)
  • 5.3 Global Female Oral Contraceptives Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Female Oral Contraceptives Sales Quantity by Application (2021-2032)
  • 6.2 Global Female Oral Contraceptives Consumption Value by Application (2021-2032)
  • 6.3 Global Female Oral Contraceptives Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Female Oral Contraceptives Sales Quantity by Type (2021-2032)
  • 7.2 North America Female Oral Contraceptives Sales Quantity by Application (2021-2032)
  • 7.3 North America Female Oral Contraceptives Market Size by Country
    • 7.3.1 North America Female Oral Contraceptives Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Female Oral Contraceptives Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Female Oral Contraceptives Sales Quantity by Type (2021-2032)
  • 8.2 Europe Female Oral Contraceptives Sales Quantity by Application (2021-2032)
  • 8.3 Europe Female Oral Contraceptives Market Size by Country
    • 8.3.1 Europe Female Oral Contraceptives Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Female Oral Contraceptives Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Female Oral Contraceptives Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Female Oral Contraceptives Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Female Oral Contraceptives Market Size by Region
    • 9.3.1 Asia-Pacific Female Oral Contraceptives Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Female Oral Contraceptives Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Female Oral Contraceptives Sales Quantity by Type (2021-2032)
  • 10.2 South America Female Oral Contraceptives Sales Quantity by Application (2021-2032)
  • 10.3 South America Female Oral Contraceptives Market Size by Country
    • 10.3.1 South America Female Oral Contraceptives Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Female Oral Contraceptives Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Female Oral Contraceptives Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Female Oral Contraceptives Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Female Oral Contraceptives Market Size by Country
    • 11.3.1 Middle East & Africa Female Oral Contraceptives Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Female Oral Contraceptives Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Female Oral Contraceptives Market Drivers
  • 12.2 Female Oral Contraceptives Market Restraints
  • 12.3 Female Oral Contraceptives Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Female Oral Contraceptives and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Female Oral Contraceptives
  • 13.3 Female Oral Contraceptives Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Female Oral Contraceptives Typical Distributors
  • 14.3 Female Oral Contraceptives Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Female Oral Contraceptives market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Female Oral Contraceptives market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Female Oral Contraceptives market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Female Oral Contraceptives market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Female Oral Contraceptives market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Female Oral Contraceptives market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Female Oral Contraceptives
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Female Oral Contraceptives market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Janssen Global Services, Allergan,plc (Actavis), Teva Pharmaceutical, Piramal Enterprises, Pfizer, Merck, Mankind Pharma, Syzygy Healthcare, Ferring B.V, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Female Oral Contraceptives market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Combination Pill
    Progestin-only Pill
    Continuous Use Pill
    Market segment by Application
    Online Sales
    Offline Sales
    Major players covered
    Bayer
    Janssen Global Services
    Allergan,plc (Actavis)
    Teva Pharmaceutical
    Piramal Enterprises
    Pfizer
    Merck
    Mankind Pharma
    Syzygy Healthcare
    Ferring B.V
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Female Oral Contraceptives product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Female Oral Contraceptives, with price, sales quantity, revenue, and global market share of Female Oral Contraceptives from 2021 to 2026.
    Chapter 3, the Female Oral Contraceptives competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Female Oral Contraceptives breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Female Oral Contraceptives market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Female Oral Contraceptives.
    Chapter 14 and 15, to describe Female Oral Contraceptives sales channel, distributors, customers, research findings and conclusion.

    Buy now